CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 108362-108473 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"These two case reports reveal significant response to omalizumab in severe steroid dependent atopic dermatitis.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T68850","span":{"begin":0,"end":111},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T68850","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T111","span":{"begin":0,"end":111},"obj":"Sentence"}],"attributes":[{"subj":"T111","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T813","span":{"begin":93,"end":110},"obj":"Disease"},{"id":"T814","span":{"begin":100,"end":110},"obj":"Disease"}],"attributes":[{"id":"A813","pred":"mondo_id","subj":"T813","obj":"http://purl.obolibrary.org/obo/MONDO_0004980"},{"id":"A814","pred":"mondo_id","subj":"T814","obj":"http://purl.obolibrary.org/obo/MONDO_0002406"},{"subj":"T813","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T814","pred":"source","obj":"CORD-19-PD-MONDO"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T374","span":{"begin":93,"end":110},"obj":"Phenotype"}],"attributes":[{"id":"A374","pred":"hp_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/HP_0001047"},{"subj":"T374","pred":"source","obj":"CORD-19-PD-HP"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ec98","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93a7"},{"id":"CORD-19-PD-MONDO","color":"#93c1ec"},{"id":"CORD-19-PD-HP","color":"#dcec93"}]}]}}